Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
North Americanome Trust (The)'s revenue for the
six
months ended in Jan. 2026 was £43.43 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jan. 2026 was £37.87 Mil.
North Americanome Trust (The)'s Revenue per Share for the
six
months ended in Jan. 2026 was £0.38.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2026 was £0.33.
During the past 13 years, North Americanome Trust (The)'s highest 3-Year average Revenue per Share Growth Rate was 81.60% per year. The lowest was -39.90% per year. And the median was 1.40% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
North Americanome Trust (The) Revenue Related Terms
North Americanome Trust (The) Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, North Americanome Trust (The)'s Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
North Americanome Trust (The) Revenue vs Asset Management Industry
For the Asset Management industry and Financial Services sector, North Americanome Trust (The)'s Revenue distribution charts can be found below:
* The bar in red indicates where North Americanome Trust (The)'s Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £37.87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
North Americanome Trust (The) (CHIX:NAITL) has a Revenue of £37.87 Mil as of Jan. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on North Americanome Trust (The) and its competitors.
Is North Americanome Trust (The)'s Revenue too high?
North Americanome Trust (The)'s current Revenue is £37.87 Mil. Overall, North Americanome Trust (The) has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does North Americanome Trust (The)'s Revenue compare to BLK and BX?
North Americanome Trust (The)'s Revenue of £37.87 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for an Asset Management company?
A good Revenue depends on the Asset Management industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on North Americanome Trust (The) and its competitors. North Americanome Trust (The)'s current Revenue is £37.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is North Americanome Trust (The) stock overvalued right now?
Based on GuruFocus' analysis, North Americanome Trust (The) (CHIX:NAITL) is currently considered Significantly Overvalued. The stock's GF Value™ is £2.81, compared to a current price of £4.46 — trading 58.7% above its estimated fair value. The current Revenue is £37.87 Mil. North Americanome Trust (The)'s overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For North Americanome Trust (The) (CHIX:NAITL), the current Revenue is £37.87 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is North Americanome Trust (The) (CHIX:NAITL) Overvalued in 2026?
Based on GuruFocus' analysis, North Americanome Trust (The) stock appears to be overvalued.
The current stock price of £4.46 is trading 58.7% above its estimated GF Value™ of £2.81.
GuruFocus considers North Americanome Trust (The) to be Significantly Overvalued.
Key valuation signals for CHIX:NAITL:
Revenue: £37.87 Mil
GF Value™: £2.81 vs. price of £4.46 (58.7% above fair value)
No single metric tells the full story. See the CHIX:NAITL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
North American Income Trust (The) PLC is a closed-end investment company. The objective of the company is to provide investors with above average dividend income and long-term capital growth through active management of a portfolio consisting predominately of S&P 500 U.S. equities.
57GF Score
Get the complete analysis for CHIX:NAITL
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:NAITL has been successfully added to your 
